Reports

Showing 15859–15867 of 23965 results

Default sorting Sort by popularity Sort by average rating Sort by latest Sort by price: low to high Sort by price: high to low

• 
  Healthcare Reports

  Restenosis Drugs – New Product Pipeline (Drugs Under Development), Market Analysis and Forecast

  Rated 0 out of 5
• 
  Automation & Technology

  Retail Robotic Solutions Market Research Report, Analysis and Forecast

  Rated 0 out of 5

  $4,299.00 – $8,499.00Price range: $4,299.00 through $8,499.00
• 
  Materials & Chemicals

  Retapamulin Market Size, Production, Sales, Average Product Price, Market Share, Import vs Export 

  Rated 0 out of 5

  $4,299.00 – $8,499.00Price range: $4,299.00 through $8,499.00
• 
  Materials & Chemicals

  Retigabine (Ezogabine) Market Size, Production, Sales, Average Product Price, Market Share, Import vs Export 

  Rated 0 out of 5

  $4,299.00 – $8,499.00Price range: $4,299.00 through $8,499.00
• 
  Materials & Chemicals

  Retinaldehyde (retinal) Market Size, Production, Sales, Average Product Price, Market Share, Import vs Export 

  Rated 0 out of 5

  $4,299.00 – $8,499.00Price range: $4,299.00 through $8,499.00
• 
  Healthcare Reports

  Retinoblastoma – Drugs Pipeline (Under Development), Market Analysis and Forecast

  Rated 0 out of 5

  $4,299.00 – $8,499.00Price range: $4,299.00 through $8,499.00
• 
  Healthcare Reports

  Retinoic Acid Receptor Alpha, Pipeline (Drugs Under Development), Market Analysis and Forecast

  Rated 0 out of 5

  $4,299.00 – $8,499.00Price range: $4,299.00 through $8,499.00
• 
  Healthcare Reports

  Retinoic Acid Receptor Gamma, Pipeline (Drugs Under Development), Market Analysis and Forecast

  Rated 0 out of 5

  $4,299.00 – $8,499.00Price range: $4,299.00 through $8,499.00
• 
  Healthcare Reports

  Retinopathy Of Prematurity Drugs – New Product Pipeline (Drugs Under Development), Market Analysis and Forecast

  Rated 0 out of 5

  $4,299.00 – $8,499.00Price range: $4,299.00 through $8,499.00